Abstract:Background To assess the differences across continental regions in terms of stroke imaging obtained for making acute revascularization therapy decisions, and to identify obstacles to participating in randomized trials involving multimodal imaging. Methods STroke Imaging Repository (STIR) and Virtual International Stroke Trials Archive (VISTA)-Imaging circulated an online survey through its website, through the websites of national professional societies from multiple countries as well as through email distribution lists from STIR and the above mentioned societies. Results We received responses from 223 centers (2 from Africa, 38 from Asia, 10 from Australia, 101 from Europe, 4 from Middle East, 55 from North America, 13 from South America). In combination, the sites surveyed administered acute revascularization therapy to a total of 25 326 acute stroke patients in 2012. Seventy-three percent of these patients received intravenous (IV) tissue plasminogen activator (tPA), and 27%, endovascular therapy. Vascular imaging was routinely obtained in 79% (152/193) of sites for endovascular therapy decisions, and also as part of standard IV tPA treatment decisions at 46% (92/198) of sites. Modality, availability and use of acute vascular and perfusion imaging before revascularization varied substantially between geographical areas. The main obstacles to participate in randomized trials involving multimodal imaging included: mainly insufficient research support and staff (50%, 79/158) and infrequent use of multimodal imaging (27%, 43/158). Conclusion There were significant variations among sites and geographical areas in terms of stroke imaging work-up used to make decisions both for intravenous and endovascular revascularization. Clinical trials using advanced imaging as a selection tool for acute revascularization therapy should address the need for additional resources and technical support, and take into consideration the lack of routine use of such techniques in trial planning.

Advanced Imaging for Acute Stroke Treatment Selection: CT, CTA, CT Perfusion, and MR Imaging

Brain Imaging for Stroke

Advanced Neuroimaging in Stroke Patients: Prediction of Tissue Fate and Hemorrhagic Transformation

Advances In Imaging Acute Ischemic Stroke: Evaluation Before Thrombectomy

Validating a Predictive Model of Acute Advanced Imaging Biomarkers in Ischemic Stroke

recent advances in imaging of acute ischemic stroke

Imaging in Acute Anterior Circulation Ischemic Stroke: Current and Future

Endovascular Therapy in Acute Ischemic Stroke: Time is Brain

Imaging Selection for Reperfusion Therapy in Acute Ischemic Stroke

International Survey of Acute Stroke Imaging Used to Make Revascularization Treatment Decisions

Neuroimaging of Acute Ischemic Stroke: Multimodal Imaging Approach for Acute Endovascular Therapy

Imaging in Neurointerventional Stroke Treatment: Review of the Recent Trials and What Your Neurointerventionalist Wants to Know from Emergency Radiologists

Priorities for Advancements in Neuroimaging in the Diagnostic Workup of Acute Stroke

Current State of Evidence for Neuroimaging Paradigms in Management of Acute Ischemic Stroke

Brain ischemia: CT and MRI techniques in acute ischemic stroke

A New Era of Extended Time Window Acute Stroke Interventions Guided by Imaging

Perfusion CT and acute stroke imaging: foundations, applications, and literature review

Imaging Acute Stroke: from One-Size-Fit-All to Biomarkers.

Recent Advances in Magnetic Resonance Imaging for Stroke Diagnosis

From “Time is Brain” to “Imaging is Brain”: A Paradigm Shift in the Management of Acute Ischemic Stroke

The Impact of Neuroimaging on Acute Stroke Treatment: Role of Computed Tomography